We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current STIM market cap is 230.37M. The company's latest EPS is USD -0.6641 and P/E is -5.27.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 17.42M | 16.45M | 18.53M | 22.49M | 31.98M |
| Operating Income | -6.86M | -8.51M | -7.73M | -11.47M | -11.01M |
| Net Income | -7.87M | -9.83M | -13.34M | -12.66M | -12.68M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 49.24M | 55.31M | 65.21M | 71.35M | 74.89M |
| Operating Income | -22.31M | -27.56M | -35.11M | -30.55M | -34.56M |
| Net Income | -27.45M | -31.19M | -37.16M | -30.19M | -43.71M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 103.81M | 96.81M | 74.12M | 140.9M | 141.99M |
| Total Liabilities | 76.16M | 77.43M | 64.74M | 109.1M | 102.46M |
| Total Equity | 27.66M | 19.39M | 9.38M | 31.8M | 39.53M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 78.66M | 141.22M | 116.88M | 115.83M | 140.9M |
| Total Liabilities | 53.16M | 56.05M | 59.82M | 81.64M | 109.1M |
| Total Equity | 25.49M | 85.18M | 57.06M | 34.19M | 31.8M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.02M | -16.98M | -22.4M | -31M | -16.99M |
| Investing | 68k | -51k | -37k | -2.41M | -219k |
| Financing | N/A | N/A | -16.37M | -6.81M | 18.98M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -28.39M | -27.98M | -30.74M | -32.04M | -31M |
| Investing | -730k | -9.84M | 6.73M | -1.32M | -2.41M |
| Financing | 2.37M | 83.01M | 207k | 22.7M | -6.81M |
| Market Cap | 230.37M |
| Price to Earnings Ratio | -5.27 |
| Price to Sales Ratio | 3.08 |
| Price to Cash Ratio | 12.48 |
| Price to Book Ratio | 7.24 |
| Dividend Yield | - |
| Shares Outstanding | 65.82M |
| Average Volume (1 week) | 930.39k |
| Average Volume (1 Month) | 979.61k |
| 52 Week Change | 94.44% |
| 52 Week High | 5.92 |
| 52 Week Low | 0.52 |
| Spread (Intraday) | 0.2 (5.71%) |
| Company Name | Neuronetics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.neurostar.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
